A groundbreaking oral medication called enlicitide reduced LDL cholesterol by approximately 60% in a major clinical trial — offering a convenient pill alternative to injectable treatments for people at high risk of heart disease.
🔗
https://www.utsouthwestern.edu/newsroom/articles/year-2026/feb-experimental-pill-bad-cholesterol.html
#Study #HeartHealth #Wellness 🌿
www.utsouthwestern.edu
Experimental pill dramatically reduces ‘bad’ cholesterol
An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as “bad” cholesterol, by up to 60%, a new phase three clinical trial published in The New England Journal of Medicine showed.
